The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Reduction rate of the maximal value of the baseline standardized uptake value on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography to predict response of breast cancer to neoadjuvant chemotherapy.
Takayuki Kadoya
No relevant relationships to disclose
Etsushi Akimoto
No relevant relationships to disclose
Ai Amioka
No relevant relationships to disclose
Keiko Kajitani
No relevant relationships to disclose
Akiko Emi
No relevant relationships to disclose
Hideo Shigematsu
No relevant relationships to disclose
Kazuo Matsuura
No relevant relationships to disclose
Norio Masumoto
No relevant relationships to disclose
Morihito Okada
No relevant relationships to disclose